Implementing AI in clinical microbiology: Key challenges ahead
American Journal of Clinical Pathology · 03.06.2025 · 163 (6) · 947-947
DOI: 10.1093/ajcp/aqaf003 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 21.02.2025. Verfasst von Diyna Altrmanini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sidra Medicine, Doha, Qatar. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
We read with great interest the article by Graf et al1 in which they reviewed the current and potential uses of artificial intelligence (AI) in clinical microbiology and how it can enhance diagnostic accuracy and efficiency.1 We fully agree with the authors, but we need to highlight and understand some of the challenges that could delay the routine implementation of AI in clinical microbiology laboratories. The potential of AI and machine learning (ML) applications is massive, but the progress toward implementation in microbiology is lagging due to lack of regulations and standards, potential poor data quality, lack of infrastructure for data storage, and a shortage of laboratory personnel experienced in AI and bioinformatics. Best-practice guidelines and regulations are still under development for the validation, implementation, and monitoring of AI and ML applications in clinical microbiology laboratories.2 Many laboratories will be hesitant to implement these innovative tools without a flexible regulatory framework that is continuously updated with the latest acquired data.2 Data quality is another major challenge because it plays a vital role in the effectiveness and accuracy of AI and ML applications.2-4 Given the vast amount of data AI uses, it is crucial to ensure that the data used for training and testing are accurate, complete, and consistent to achieve the best possible results.2-4 Ongoing monitoring and maintenance of the data generated are also essential to ensure consistent data quality over time and to avoid inaccurate results or biased outcomes.2-4
Autor:innen und Institutionen
- Sidra Medicine, Doha, Qatar.
- Weill Cornell Medicine in Qatar, Doha, Qatar.
ORCID-Profile: Mohammed Suleiman
Zitieren
APA
Altrmanini, D., Hassan, I., Pérez-López, A., & Suleiman, M. (2025). Implementing AI in clinical microbiology: Key challenges ahead. American Journal of Clinical Pathology, 163(6), 947-947. https://doi.org/10.1093/ajcp/aqaf003
Vancouver
Altrmanini D, Hassan I, Pérez-López A, Suleiman M. Implementing AI in clinical microbiology: Key challenges ahead. American Journal of Clinical Pathology. 2025;163(6):947-947. doi:10.1093/ajcp/aqaf003
BibTeX
@article{Altrmanini2025,
author = {Altrmanini, Diyna and Hassan, Ibrahim and Pérez-López, Andrés and Suleiman, Mohammed},
title = {Implementing AI in clinical microbiology: Key challenges ahead},
journal = {American Journal of Clinical Pathology},
year = {2025},
volume = {163},
number = {6},
pages = {947--947},
doi = {10.1093/ajcp/aqaf003}
}
EUVIMED